Neurobiology of schizophrenia and translation into new treatments

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We need to discover novel pharmacological therapies that operate on pathways beyond DAD2R, that will be more effective and have fewer side effects. To identify such agents, we need a better understanding of the biological basis of schizophrenia.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2021

Funding Scheme: Research Fellowships

Funding Amount: $763,845.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychiatry (incl. Psychotherapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | molecular markers | neuroinflammation | schizophrenia | sex hormones